CONTROL OF MALIGNANT METASTASES BY ICRF-159

被引：116
|
作者：
HELLMANN, K
BURRAGE, K
机构：
来源：
NATURE | 1969年 / 224卷 / 5216期
关键词：
D O I：
10.1038/224273a0
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：273 / &
相关论文
共 50 条
  • [31] TREATMENT OF KAPOSIS SARCOMA WITH ICRF-159 (NSC-129943)
    OLWENY, CLM
    MASABA, JP
    SIKYEWUNDA, W
    TOYA, T
    CANCER TREATMENT REPORTS, 1976, 60 (01): : 111 - 113
  • [32] BIOLOGICAL PROPERTIES OF ICRF-159 AND RELATED BIS(DIOXOPIPERAZINE) COMPOUNDS
    HERMAN, EH
    WITIAK, DT
    HELLMANN, K
    WARAVDEKAR, VS
    ADVANCES IN PHARMACOLOGY AND CHEMOTHERAPY, 1982, 19 : 249 - 290
  • [33] ICRF-159对柔毛霉素药效的影响
    王德昌
    国外医学参考资料(肿瘤学分册), 1975, (01) : 23 - 23
  • [34] PHASE-II EVALUATION OF DIBROMODULCITOL, ICRF-159, AND MAYTANSINE FOR SARCOMAS
    BORDEN, EC
    ASH, A
    ENTERLINE, HT
    ROSENBAUM, C
    LAUCIUS, JF
    PAUL, AR
    FALKSON, G
    LERNER, H
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (04): : 417 - 420
  • [35] COMBINED TREATMENT OF SOFT-TISSUE AND OSTEOSARCOMAS BY RADIATION AND ICRF-159
    RYALL, RDH
    HANHAM, IWF
    NEWTON, KA
    HELLMANN, K
    BRINKLEY, DM
    HJERTAAS, OK
    CANCER, 1974, 34 (04) : 1040 - 1045
  • [36] ISOLATION AND CHARACTERIZATION OF A SUBLINE OF CHO CELLS WITH INDUCED RESISTANCE TO ICRF-159
    KENWRICK, SJ
    CREIGHTON, AM
    BRITISH JOURNAL OF CANCER, 1982, 46 (03) : 504 - 505
  • [37] RANDOMIZED CLINICAL-TRIAL COMPARING 2 DOSE REGIMENS OF ICRF-159 IN REFRACTORY MALIGNANT-LYMPHOMAS
    OCONNELL, MJ
    BEGG, CB
    SILVERSTEIN, MN
    GLICK, JH
    OKEN, MM
    CANCER TREATMENT REPORTS, 1980, 64 (12): : 1355 - 1358
  • [38] ICRF-159 INDUCED ENHANCEMENT OF RADIATION RESPONSE IN COMBINED MODALITY THERAPIES
    KOVACS, CJ
    EVANS, MJ
    BURHOLT, DR
    SCHENKEN, LL
    RADIATION RESEARCH, 1978, 74 (03) : 580 - 580
  • [39] ADJUVANT ORAL RAZOXANE (ICRF-159) IN RESECTABLE COLORECTAL-CANCER
    GILBERT, JM
    HELLMANN, K
    EVANS, M
    CASSELL, PG
    STOODLEY, B
    ELLIS, H
    WASTELL, C
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 8 (03) : 293 - 299
  • [40] A TRIAL OF RAZOXANE (ICRF-159) IN PATIENTS WITH PRIOR THERAPY FOR HODGKINS LYMPHOMA
    CORDER, MP
    MCFADDEN, DB
    BELL, SJ
    CANCER, 1984, 54 (08) : 1496 - 1498
12345